Keywords: OSI Pharma, Astellas, M&A, Tarceva, White knight

OSI Pharma board looking for “white knight,” as it rejects Astellas' $3.5 billion offer

Article | 16 March 2010

US drugmaker OSI Pharmaceuticals has formally rejected a $3.5-billion takeover bid from Japanese drug major Astellas, telling shareholders yesterday that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in